NCT03878524 2024-03-04Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialOHSU Knight Cancer InstitutePhase 1 Terminated2 enrolled
NCT00710528 2012-08-31Dose Escalation Study of CAL-101 in Select Relapsed or Refractory Hematologic MalignanciesGilead SciencesPhase 1 Completed192 enrolled